Report of incidence and mortality in China cancer registries, 2009

来源 :Chinese Journal of Cancer Research | 被引量 : 0次 | 上传用户:frog_t
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: The National Central Cancer Registry (NCCR) collected cancer registration data in 2009 from local cancer registries in 2012, and analyzed to describe cancer incidence and mortality in China. Methods: On basis of the criteria of data quality from NCCR, data submitted from 104 registries were checked and evaluated. There were 72 registries’ data qualified and accepted for cancer registry annual report in 2012. Descriptive analysis included incidence and mortality stratified by area (urban/rural), sex, age group and cancer site. The top 10 common cancers in different groups, proportion and cumulative rates were also calculated. Chinese population census in 1982 and Segi’s population were used for age-standardized incidence/mortality rates. Results: All 72 cancer registries covered a total of 85,470,522 population (57,489,009 in urban and 27,981,513 in rural areas). The total new cancer incident cases and cancer deaths were 244,366 and 154,310, respectively. The morphology verified cases accounted for 67.23%, and 3.14% of incident cases only had information from death certifications. The crude incidence rate in Chinese cancer registration areas was 285.91/100,000 (males 317.97/100,000, females 253.09/100,000), age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 146.87/100,000 and 191.72/100,000 with the cumulative incidence rate (0-74 age years old) of 22.08%. The cancer incidence and ASIRC were 303.39/100,000 and 150.31/100,000 in urban areas whereas in rural areas, they were 249.98/100,000 and 139.68/100,000, respectively. The cancer mortality in Chinese cancer registration areas was 180.54/100,000 (224.20/100,000 in males and 135.85/100,000 in females), age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 85.06/100,000 and 115.65/100,000, and the cumulative incidence rate (0-74 age years old) was 12.94%. The cancer mortality and ASMRC were 181.86/100,000 and 80.86/100,000 in urban areas, whereas in rural areas, they were 177.83/100,000 and 94.40/100,000 respectively. Lung cancer, gastric cancer, colorectal cancer, liver cancer, esophageal cancer, pancreas cancer, encephaloma, lymphoma, female breast cancer and cervical cancer, were the most common cancers, accounting for 75% of all cancer cases in urban and rural areas. Lung cancer, gastric cancer, liver cancer, esophageal cancer, colorectal cancer, pancreatic cancer, breast cancer, encephaloma, leukemia and lymphoma accounted for 80% of all cancer deaths. The cancer spectrum showed difference between urban and rural areas, males and females. The main cancers in rural areas were cancers of the stomach, followed by esophageal cancer, lung cancer, liver cancer and colorectal cancer, whereas the main cancer in urban areas was lung cancer, followed by liver cancer, gastric cancer and colorectal cancer. Conclusions: The coverage of cancer registration population has been increasing and data quality is improving. As the basis of cancer control program, cancer registry plays an important role in making anticancer strategy in medium and long term. As cancer burdens are different between urban and rural areas in China, prevention and control should be implemented based on practical situation. Objective: The National Central Cancer Registry (NCCR) collected cancer registration data in 2009 from local cancer registries in 2012, and analyzed to describe cancer incidence and mortality in China. Methods: On basis of the criteria of data quality from NCCR, data submitted from There were 72 registries’ data qualified and accepted for cancer registry annual report in 2012. Descriptive analysis including incidence and mortality stratified by area (urban / rural), sex, age group and cancer site. The top 10 common cancers in different groups, proportion and cumulative rates were also calculated. Chinese population census in 1982 and Segi’s population were used for age-standardized incidence / mortality rates. Results: All 72 cancer regstries covered a total of 85,470,522 population (57,489,009 in urban and 27,981,513 in rural areas). The total new cancer incident cases and cancer deaths were 244,366 and 154,310, respectively. The relationship ied cases accounted for 67.23%, and 3.14% of incident cases only had information from death certifications. The crude incidence rate in Chinese cancer registration areas was 285.91 / 100,000 (males 317.97 / 100,000, females 253.09 / 100,000) by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 146.87 / 100,000 and 191.72 / 100,000 with the cumulative incidence rate (0-74 age years old) of 22.08%. The cancer incidence and ASIRC were 303.39 / 100,000 and 150.31 / 100,000 in urban areas but in rural areas, they were 249.98 / 100,000 and 139.68 / 100,000, respectively. The cancer mortality in Chinese cancer registration areas was 180.54 / 100,000 (224.20 / 100,000 in males and 135.85 / 100,000 in females), age -standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 85.06 / 100,000 and 115.65 / 100,000, and the cumulative incidence rate (0-74 age years old) was 12.94%. The cancer mortality anLung cancer, gastric cancer, colorectal cancer, liver cancer, esophageal cancer, pancreas cancer, encephaloma, Lymphoma, female breast cancer and cervical cancer, were the most common cancers, accounting for 75% of all cancer cases in urban and rural areas. Lung cancer, gastric cancer, liver cancer, esophageal cancer, colorectal cancer, pancreatic cancer, breast cancer, encephaloma, leukemia and lymphoma accounted for 80% of all cancer deaths. The cancer spectrum showed difference between urban and rural areas, males and females. The main cancers in rural areas were cancers of the stomach, followed by esophageal cancer, lung cancer, liver cancer and colorectal cancer, and the the main cancer in urban areas was lung cancer, followed by liver cancer, gastric cancer and colorectal cancer. Conclusions: The coverage of cancer registration population As the basis of cancer control program, cancer registry plays an important role in making anticancer strategy in medium and long term. As cancer cancer is different between urban and rural areas in China, prevention and control should be implemented based on practical situation.
其他文献
建立方盒拉深件有限元模型,用不同的坯料板厚、网格尺寸进行成形模拟计算,讨论了坯料网格尺寸对计算精度的影响;提出了合适的坯料网格尺寸的确定原则及其定量标准。
等通道转角挤压是获得块体超细晶材料的一种重要方法。本文针对粉末材料的特点,采用体积可压缩刚粘塑性有限元法对纯铝粉末多孔材料的等通道转角挤压过程进行数值模拟,获得了粉
会议
在研究高温塑性变形中孔隙性缺陷自修复过程中,发现金属材料裂纹修复过程中存在与生物损伤愈合过程类似的现象,包括瘢痕形成、瘢痕多孔疏松化和硬化等。研究金属材料所具有的类
会议
本文分析了2006年8月北京大学出版社和中国林业大学出版社联合出版的国家“十一五”规划教材《锻造工艺过程及模具设计》的写作特色。该教材尽量引用国内外有关生产开发和研
会议
随着资源、能源与环境压力日益迫切,世界各国政府在过去十年内相继设立专门计划,投入专项资金,支持镁材料的研究与开发。自2001年中国科技部启动“十五”国家科技攻关计划“镁合
镁是金属材料中最轻量的材料,对于环保对策、节省能源、节省资源来说;镁是在今后的发展中倍受期待的为数不多的新材料之一。为了将镁的优秀的特性有效利用在传输机械领域中;进一
会议
本文首先对长安汽车集团公司进行了简单介绍,然后讨论了镁合金在长安汽车上的应用,最后提出了长安要加速推进镁合金汽车的“中国制造”。
玻利维亚的安第斯山区是巴西利什曼原虫引起的皮肤利什曼病和粘膜皮肤利什曼病流行的高发区。近期研究表明该地区尚有利什曼原虫亚马孙亚种(Leishmaniaamazonensis)的流行,内
新一代的汽车,要求对乘客提供更好的保护和拥有更高的安全性能,并且具备更为完善的车载电子系统。这些导致新一代汽车的重量不断增加。但是各国政府却纷纷通过减少二氧化碳排放
会议
铝、聚合物、轻质钢和镁,在北美汽车工业的赛场上竞争着。但不像镁在一辆车中只使用了不到6kg,其他这些“轻”材料目前用量在125—900kg不等。本文讨论了轻质零部件的使用。以